פרבסטאטין טבע 20 מג
teva israel ltd - pravastatin sodium - טבליה - pravastatin sodium 20 mg - pravastatin
אבירטרון טבע 250 מג
teva israel ltd - abiraterone acetate - טבליה - abiraterone acetate 250 mg - abiraterone
פינגולימוד טבע
teva israel ltd - fingolimod as hydrochloride - קפסולות - fingolimod as hydrochloride 0.5 mg - fingolimod
טרזוסין טבע 5 מג
teva israel ltd - terazosin as hydrochloride dihydrate - טבליה - terazosin as hydrochloride dihydrate 5 mg - terazosin
טבעפירין
teva pharmaceutical industries ltd, israel - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
טבעפירין
teva pharmaceutical industries ltd, israel - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
טבעפירין
teva israel ltd - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 100 mg - acetylsalicylic acid
טבעפירין
teva pharmaceutical industries ltd, israel - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 100 mg - acetylsalicylic acid
סימבסטאטין טבע 20 מג
teva israel ltd - simvastatin - טבליה - simvastatin 20 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvastatin-teva is indicated to: - reduce the risk of total mortality by reducing coronary death - reduce the risk of non-fatal myocardial infarction - reduce the risk for undergoing myocardial revascularization procedures. - reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvastatin-teva is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvastatin-teva therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simvastatin-teva is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to thes
סימבסטאטין טבע 10 מג
teva israel ltd - simvastatin - טבליה - simvastatin 10 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvastatin-teva is indicated to: - reduce the risk of total mortality by reducing coronary death - reduce the risk of non-fatal myocardial infarction - reduce the risk for undergoing myocardial revascularization procedures.- reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvastatin-teva is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvastatin-teva therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios.homozygous familial hypercholesterolemia: simvastatin-teva is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these